Short chain fatty acids and their receptors: new metabolic targets.

[1]  J. Olefsky,et al.  Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. , 2011, Trends in pharmacological sciences.

[2]  G. Tsujimoto,et al.  Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 , 2005, Nature Medicine.

[3]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[4]  T. Wolever,et al.  The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. , 2010, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[5]  C. Dejong,et al.  Short chain fatty acids exchange across the gut and liver in humans measured at surgery. , 2009, Clinical nutrition.

[6]  E. Verdin,et al.  Acetate metabolism and aging: An emerging connection , 2010, Mechanisms of Ageing and Development.

[7]  Hua V. Lin,et al.  Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms , 2012, PloS one.

[8]  T. Wolever,et al.  Effect of rectal infusion of short chain fatty acids in human subjects. , 1989, The American journal of gastroenterology.

[9]  Pat Baird,et al.  Health benefits of dietary fiber. , 2009, Nutrition reviews.

[10]  James W. Anderson,et al.  Propionate Inhibits Hepatocyte Lipid Synthesis , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  S. Costagliola,et al.  G protein-coupled receptors: mutations and endocrine diseases , 2011, Nature Reviews Endocrinology.

[12]  C. Venkataraman,et al.  The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking. , 2005, Immunology letters.

[13]  D. Kipnis,et al.  Effect of short-chain fatty acids on plasma insulin in ruminant and nonruminant species. , 1968, Endocrinology.

[14]  T. Wolever,et al.  Intravenous Acetate Elicits a Greater Free Fatty Acid Rebound in Normal than Hyperinsulinaemic Humans , 2012, European Journal of Clinical Nutrition.

[15]  D. Lindsay,et al.  Carbohydrate and Lipid Metabolism , 1975 .

[16]  H. Yamashita,et al.  Improvement of Obesity and Glucose Tolerance by Acetate in Type 2 Diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) Rats , 2007, Bioscience, biotechnology, and biochemistry.

[17]  J. V. Evans,et al.  Capillary gas chromatographic analysis of volatile and non-volatile organic acids from biological samples as the t-butyldimethylsilyl derivatives. , 1985, Journal of chromatographic science.

[18]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[19]  T. Wolever,et al.  Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects , 2009, British Journal of Nutrition.

[20]  Yang Li,et al.  Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. , 2008, Endocrinology.

[21]  T. Wolever,et al.  Acarbose raises serum butyrate in human subjects withimpaired glucose tolerance , 2000, British Journal of Nutrition.

[22]  Y. S. Kim,et al.  A simple quantitative method to determine short chain fatty acid levels in biological fluids. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[23]  Takafumi Hara,et al.  Free fatty acid receptors and drug discovery. , 2008, Biological & pharmaceutical bulletin.

[24]  C. Johnston,et al.  Vinegar improves insulin sensitivity to a high-carbohydrate meal in subjects with insulin resistance or type 2 diabetes. , 2004, Diabetes care.

[25]  G. Frost,et al.  Propionate. Anti-obesity and satiety enhancing factor? , 2011, Appetite.

[26]  O. Velazquez,et al.  Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications. , 1997, Advances in experimental medicine and biology.

[27]  R. Curi,et al.  Propionate inhibits glucose‐induced insulin secretion in isolated rat pancreatic islets , 2007, Cell biochemistry and function.

[28]  R. D. de Souza,et al.  Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.

[29]  S. Coughlin,et al.  Anatomical Profiling of G Protein-Coupled Receptor Expression , 2008, Cell.

[30]  J. Anderson,et al.  Plant fiber. Carbohydrate and lipid metabolism. , 1979, The American journal of clinical nutrition.

[31]  T. Alquier,et al.  Lipid receptors and islet function: therapeutic implications? , 2009, Diabetes, obesity & metabolism.

[32]  Leigh A. Stoddart,et al.  Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3 , 2009, British journal of pharmacology.

[33]  C. Dejong,et al.  Application of liquid chromatography-mass spectrometry to measure short chain fatty acids in blood. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[34]  J. Anderson,et al.  Hypocholesterolemic effects of oat products. , 1990, Advances in experimental medicine and biology.

[35]  C. Lieber,et al.  Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man. , 1968, Journal of lipid research.

[36]  H. Englyst,et al.  Measurement of starch fermentation in the human large intestine. , 1991, Canadian journal of physiology and pharmacology.

[37]  Carol S. Johnston,et al.  Examination of the Antiglycemic Properties of Vinegar in Healthy Adults , 2010, Annals of Nutrition and Metabolism.

[38]  Dali Li,et al.  Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets , 2012, Acta Pharmacologica Sinica.

[39]  S. Coughlin,et al.  Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. , 2007, The Journal of clinical investigation.

[40]  T. Wolever,et al.  Do colonic short-chain fatty acids contribute to the long-term adaptation of blood lipids in subjects with type 2 diabetes consuming a high-fiber diet? , 2002, The American journal of clinical nutrition.

[41]  G. Feng,et al.  Regulation of pancreatic islet gene expression in mouse islets by pregnancy. , 2010, The Journal of endocrinology.

[42]  M. Krempf,et al.  Production rates and metabolism of short-chain fatty acids in the colon and whole body using stable isotopes. , 2003, The Proceedings of the Nutrition Society.

[43]  R. Hammer,et al.  Fasting-induced hypothermia and reduced energy production in mice lacking acetyl-CoA synthetase 2. , 2009, Cell metabolism.

[44]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[45]  Lawrence A Leiter,et al.  Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. , 1997, Metabolism: clinical and experimental.

[46]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[47]  M. Bohlooly-y,et al.  Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. , 2011, American journal of physiology. Endocrinology and metabolism.

[48]  S. Tunaru,et al.  GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. , 2009, Trends in pharmacological sciences.

[49]  B. Hudson,et al.  Selective Orthosteric Free Fatty Acid Receptor 2 (FFA2) Agonists , 2011, The Journal of Biological Chemistry.

[50]  Florian Lang,et al.  Significance of Short Chain Fatty Acid Transport by Members of the Monocarboxylate Transporter Family (MCT) , 2012, Neurochemical Research.

[51]  J. Schrezenmeir,et al.  Effect of gut-derived acetate on oral glucose tolerance in man. , 1988, Clinical science.

[52]  M. Krempf,et al.  Effect of acetate and propionate on fasting hepatic glucose production in humans. , 1995, European journal of clinical nutrition.

[53]  H. Waterham,et al.  Clinical variability of isovaleric acidemia in a genetically homogeneous population , 2012, Journal of Inherited Metabolic Disease.

[54]  E. Murphy,et al.  Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models , 2010, Gut.

[55]  C. Johnston,et al.  Vinegar: medicinal uses and antiglycemic effect. , 2006, MedGenMed : Medscape general medicine.

[56]  T. Iwanaga,et al.  Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine , 2006, Cell and Tissue Research.

[57]  J. Cummings,et al.  Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. , 1990, The American journal of gastroenterology.

[58]  T. Wolever,et al.  Negative association of acetate with visceral adipose tissue and insulin levels , 2012, Diabetes, metabolic syndrome and obesity : targets and therapy.

[59]  T. Hockaday,et al.  Acetate tolerance and the kinetics of acetate utilization in diabetic and nondiabetic subjects. , 1990, The American journal of clinical nutrition.

[60]  H. Hamer.  Short chain fatty acids and colonic health , 2009 .

[61]  Takafumi Hara,et al.  Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41) , 2011, Proceedings of the National Academy of Sciences.

[62]  B. Olde,et al.  Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. , 2003, Biochemical and biophysical research communications.

[63]  A. Tiengo,et al.  Effect of Ethanol, Acetaldehyde, and Acetate on Insulin and Glucagon Secretion in the Perfused Rat Pancreas , 1981, Diabetes.

[64]  C. W. Moss,et al.  Analysis of short-chain acids from anaerobic bacteria by high-performance liquid chromatography , 1982, Journal of clinical microbiology.

[65]  S. Dowell,et al.  The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids* , 2003, The Journal of Biological Chemistry.

[66]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[67]  S. Karaki,et al.  Expression of the short-chain fatty acid receptor, GPR43, in the human colon , 2008, Journal of Molecular Histology.

[68]  D. Williamson,et al.  Origins of blood acetate in the rat. , 1977, Biochemical Journal.

[69]  T. Wolever,et al.  Interaction between colonic acetate and propionate in humans. , 1991, The American journal of clinical nutrition.

[70]  W. Cefalu,et al.  Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.

[71]  Yinghe Hu,et al.  Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. , 2012, Journal of genetics and genomics = Yi chuan xue bao.

[72]  K. McMartin,et al.  Fomepizole for the treatment of methanol poisoning. , 2001, The New England journal of medicine.

[73]  Ki-Choon Choi,et al.  Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. , 2005, Endocrinology.

[74]  T. Wolever,et al.  Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α , 2009, British Journal of Nutrition.